These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 144323)

  • 1. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin - plasmaprotein interactions. Current status.
    Steinbuch M
    Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):217-38. PubMed ID: 7048490
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 5. Actions and interactions of antithrombin and heparin.
    Rosenberg RD
    N Engl J Med; 1975 Jan; 292(3):146-51. PubMed ID: 127943
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of coagulation and platelets by candidate membranes of implantable devices in a whole blood model without soluble anticoagulant.
    Sokolov A; Hellerud BC; Tønnessen TI; Johannessen EA; Mollnes TE
    J Biomed Mater Res A; 2013 Feb; 101(2):575-81. PubMed ID: 22949225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.
    JELJASZEWICZ J; NIEWIAROWSKI S; POPLAWSKI A; PROKOPOWICZ J; WOROWSKI K
    Thromb Diath Haemorrh; 1965 Jun; 13():457-69. PubMed ID: 14347867
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
    Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
    Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation and related plasma enzymes in inflammation.
    Donaldson VH
    Ser Haematol; 1970; 3(1):39-95. PubMed ID: 4943386
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of biologic properties of a polysulfated chondroitin, A73025.
    Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
    [No Abstract]   [Full Text] [Related]  

  • 16. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of inhibition of blood coagulation (author's transl)].
    Kurachi K
    Tanpakushitsu Kakusan Koso; 1980 Dec; 25(13):1031-40. PubMed ID: 7025099
    [No Abstract]   [Full Text] [Related]  

  • 18. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.